A detailed history of Hrt Financial LP transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 140,909 shares of GTHX stock, worth $511,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,909
Holding current value
$511,499
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.1 - $4.83 $295,908 - $680,590
140,909 New
140,909 $608,000
Q1 2023

May 12, 2023

BUY
$2.57 - $8.16 $96,387 - $306,040
37,505 Added 34.96%
144,780 $388,000
Q4 2022

Feb 10, 2023

BUY
$5.19 - $13.5 $556,757 - $1.45 Million
107,275 New
107,275 $582,000
Q2 2022

Aug 12, 2022

SELL
$4.04 - $8.51 $824,426 - $1.74 Million
-204,066 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.6 - $11.02 $1.55 Million - $2.25 Million
204,066 New
204,066 $1.55 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $155M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.